Cadwalader Wins ‘M&A Impact Deal of the Year’ at 2015 LMG Life Sciences Awards

Sep 17, 2015

Contact(s)

Kimberly Brooks
New York
+1 212 504 5652
kimberly.brooks@cwt.com

Cadwalader, Wickersham & Taft LLP, a leading international law firm to global corporations and financial institutions,  was recognized with an “M&A Impact Deal of the Year Award” at the 2015 LMG Life Sciences Awards in New York City on September 16.

Cadwalader won the award for its role in the $15.8 billion sale of Salix Pharmaceuticals, Ltd., a leading U.S. specialty pharmaceutical company, to Valeant Pharmaceuticals International, Inc.  Cadwalader represented Salix in connection with the transaction.

“We are proud to receive such a prestigious award which recognizes our reputation for securing the best possible deals for our clients,” said Christopher Cox, Chair of the Corporate Group, who led the transaction. “'This is the result of a concerted effort on the part of our team to really understand the markets our clients operate within and invest time in listening and working closely with them to find a better way of delivering advice and adding value.”

LMG Life Sciences hosted the awards ceremony to recognize key law firms, lawyers and the innovative work being accomplished throughout the life sciences industry. The lawyers and law firms selected are “subject to stringent peer review and editorial discretion” and have participated in “case matters that have made headlines with regards to legal precedent and/or other notable factors that have remained at the forefront of conversation in both the United States and Canada.”

Cadwalader News

ACI Summit on Controlled Substances: Regulation, Litigation and Enforcement

Jodi Avergun is speaking at this ACI event on January 30 in Washington, DC.

Cadwalader Subscription Center